logo
15:59 Dec 12

Remus Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
753.65
+27.70 (+3.82%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Remus Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
753.65
+27.70 (+3.82%)
15:59 Dec 12
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

22/100
Expensive Valuation

Technical

39/100
Technically Neutral

Strength

3

Weakness

1

Opportunity

0

Threats

0

11.36 %

ROE %

6.71 %

ROA %

24.67

EPS

434.40

BVPS

4.68 %

Net Profit Margin

Mar 2024 Mar 2025
Net Sales
212.5 620.36
Operating Expenses +
184.69 574.67
Raw Material
164.99 541.31
Increase Decrease in Cost
-0.67 -8.44
Other Manufacturing Expense
0 0
Employee Cost
7.42 13.11
Miscellaneous Expenses
342.93 1111.31
Operating Profit
27.81 45.69
Other Income
5.4 4.98
Depreciation
0.9 1.87
Interest
0.48 1.46
Profit before tax and exceptio..
31.83 47.34
Exceptional Items
0 0
PBT
31.83 47.34
Provision for Taxation
5.85 8.92
Net Profit
25.98 38.42
NET Profit after MI
25.98 29.07
EPS
152.01 65.21
Operating Profit Margin (%)
13.09 7.37
Net Profit Margin (%)
12.23 4.69

Remus Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: